Dr. Shafik Hanna-Moussa, MD
What this data tells you about Dr. Hanna-Moussa
Dr. Shafik Hanna-Moussa is a cardiovascular disease in Longview, TX, with 19 years in practice. Based on federal Medicare data, Dr. Hanna-Moussa performed 2,256 Medicare services across 1,995 unique beneficiaries.
Between the years covered by Open Payments, Dr. Hanna-Moussa received a total of $34,036 from 42 pharmaceutical and/or device companies across 480 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in cardiovascular disease. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Hanna-Moussa is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
Medicare Practice Summary
Medicare Utilization ↗Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Echocardiogram, transthoracic | 415 | $50 | $687 |
| EKG interpretation and report | 377 | $6 | $19 |
| Office visit, established patient (30-39 min) | 336 | $68 | $289 |
| Initial hospital admission, moderate complexity | 137 | $101 | $300 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | 97 | $15 | $49 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | 97 | $10 | $33 |
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 92 | $55 | $265 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 85 | $10 | $173 |
| Hospital follow-up visit, moderate complexity | 85 | $62 | $159 |
| Remote pacemaker monitoring, 90 days | 75 | $20 | $68 |
| New patient office visit (45-59 min) | 55 | $99 | $375 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 53 | $2 | $47 |
| Ultrasound of heart, follow-up | 45 | $18 | $340 |
| Office visit, established patient (20-29 min) | 45 | $48 | $204 |
| Cardiac catheterization | 42 | $191 | $3,680 |
| Hospital follow-up visit, low complexity | 42 | $37 | $86 |
| Ultrasound of heart blood flow, valves and chambers, follow-up | 35 | $5 | $88 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system | 31 | $13 | $132 |
| Review by radiologist of both arms or legs arteries image | 21 | $72 | $316 |
| Initial hospital admission, high complexity | 20 | $136 | $441 |
| Ultrasound of heart blood flow, valves and chambers | 18 | $14 | $177 |
| Coronary stent placement | 15 | $394 | $1,938 |
| Initial hospital care with straightforward or low level of medical decision making, per day, if using time, at least 40 minutes | 15 | $65 | $222 |
| Ultrasound of heart with probe in esophagus, with report | 12 | $83 | $831 |
| Heart rhythm review and interpretation of continous external ekg over 8-15 days | 11 | $20 | $61 |
Industry Payment Transparency
Open Payments through 2024 ↗Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
Payments by company (2024)
Associated products mentioned in payments ›
Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Hanna-Moussa is a cardiac & cardiac specialist, with moderate Medicare volume, and high industry engagement (low-engagement, top 14%), with 19 years of practice experience.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Hanna-Moussa experienced with echocardiogram, transthoracic?
Does Dr. Hanna-Moussa receive payments from pharmaceutical companies?
How do Dr. Hanna-Moussa's costs compare to other cardiovascular diseases in Longview?
What does Data Coverage mean?
Is this data up to date?
Explore related providers
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology